Terrie Curran
CIK 1690298 · President and Chief Executive · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.73M
Companies
4
Total Filings
56
Lifetime Open-Market Net
-$3.79M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 23,526 | $25.92 | $609.8K | -$94.2K | 8 | 2026-06-09 |
| PHAT | President and Chief Executive | 364,305 | $8.57 | $3.12M | -$996.6K | 19 | 2025-03-03 |
| Myovant Sciences Ltd. (MYOV) Delisted | Director | 0 | $26.98 | $0 | -$1.34M | 11 | 2023-03-10 |
| CELGENE CORP /DE/ (CELGZ) Delisted | PRES., GLBL INFLAM. AND IMMUN. | 19,341 | — | — | -$1.36M | 17 | 2019-11-22 |
Recent Filings · Page 3 of 6
56 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-03 | ARQT | Grant (A) | +4,312 | $0 | EDGAR |
| 2022-05-20 | PHAT | Grant (A) | +12,000 | $0 | EDGAR |
| 2022-05-16 | PHAT | Buy (P) | +20,500 | $151.8K | EDGAR |
| 2022-03-11 | PHAT | — | — | $0 | EDGAR |
| 2022-01-21 | PHAT | Grant (A) | +41,250 | $0 | EDGAR |
| 2021-11-09 | Myovant Sciences Ltd. (MYOV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-13 | Myovant Sciences Ltd. (MYOV) Delisted | Mixed | — | -$87.0K | EDGAR |
| 2021-09-03 | Myovant Sciences Ltd. (MYOV) Delisted | Mixed | — | -$842.7K | EDGAR |
| 2021-06-11 | ARQT | Grant (A) | — | $0 | EDGAR |
| 2021-03-23 | PHAT | Mixed | — | -$418.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.